Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 4

eBook: US $89 Special Offer (PDF + Printed Copy): US $167
Printed Copy: US $122
Library License: US $356
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-1-68108-482-4 (Print)
ISBN: 978-1-68108-481-7 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810848171170401

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.

The fourth volume of the book brings forth reviews on biomarkers and new drugs used for treating gastrointestinal cancer and breast cancer. The volume also covers the topics of adjuvant therapy, cancer nanodrugs and the role of adiponectin and dicycloplatin in cancer therapy.

Preface

Frontiers in Clinical Drug Research - Anti-Cancer Agents presents on recent developments in various therapeutic approaches against different types of cancer. The book is a valuable resource for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for devising research plans in anti-cancer research and developing clinical trials.

The chapters are written by authorities in the field. The contents of this volume represent exciting recent researches on advanced gastrointestinal cancers, breast cancer, cancer chemo-prevention and treatment, clinical anticancer nanodrug, adiponectin-based therapeutics, cancer vaccines, and chemotherapy medication. I hope that the readers will find these reviews valuable and thought provoking so that they may trigger further research in the quest for the new and novel therapies against cancers.

I am grateful for the timely efforts made by the editorial personnel, especially Mr. Mahmood Alam (Director Publications), and Mr. Shehzad Naqvi (Senior Manager Publications) at Bentham Science Publishers.

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
UK

RELATED BOOKS

.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.
.Avastin and Malignant Gliomas .
.Cutting Edge Therapies for Cancer in the 21 Century.